Ingredients/Dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate
Dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetateCAS 31717-87-0
Is Dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate restricted in cosmetics?
Dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate is prohibited in EU CosIng, ASEAN and UK OPSS. Markets not named here hold no entry for it, which is not a clearance.
- CAS
- 31717-87-0
- INCI
- Dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate
- Data refreshed
- 2026-10-12
Regulatory status
What this means
Dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate has regulatory signals in EU CosIng, ASEAN, UK OPSS. Review the source links above for the official conditions and latest updates.
Recent regulatory changes
No recorded regulatory changes for Dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate yet.
Common questions
- Is Dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate restricted in EU cosmetics?
- Dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate is prohibited in EU cosmetics according to EU CosIng Annex II.
- Is Dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate restricted under the ASEAN Cosmetic Directive?
- Dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate is prohibited under the ASEAN Cosmetic Directive Annex II.
- Is Dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate restricted in UK OPSS?
- Dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate is prohibited in cosmetics under UK OPSS.
- What is the CAS number for Dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate?
- The CAS number for Dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate is 31717-87-0.
Check this ingredient in a formula across 11 markets
This page covers one ingredient on its own. Sign up free to check it at your actual concentration, in a full formula, with GHS hazards and per-market verdicts.